RARECast
A podcast by RARECast - Thursdays
548 Episodes
-
Crowdsourcing Therapeutic Approaches for an Ultra-Rare Disease
Published: 2/5/2020 -
Delivering Oligonucleotide Therapies to Any Cell Type
Published: 1/29/2020 -
Protalix Looks Beyond Biobetters
Published: 1/22/2020 -
Driving N-of-1 Therapies for Ultra-Rare Disease Patients
Published: 1/15/2020 -
Cutting the Time and Cost of Drug Discovery with MicroOrgans
Published: 1/8/2020 -
Acquisition Combines Two Pipelines for Rare Skin Diseases
Published: 1/2/2020 -
Programming Cells to Produce Neuroprotective Factors to Treat ALS
Published: 12/26/2019 -
Origin's Rapid Path to Seek Approval for Treatment of Ultra-Rare Metabolic Condition
Published: 12/18/2019 -
Developing a Common Language for Rare Diseases
Published: 12/11/2019 -
Why Payers Lag Drug Developers and Regulators in Embracing Real-World Evidence
Published: 12/4/2019 -
How a Brother's Love Is Forging a Path for Customized Therapies for Rare Disease Patients
Published: 11/27/2019 -
Addressing the Barriers to Accessing Experimental Therapies
Published: 11/20/2019 -
A Journey to Advocacy
Published: 11/13/2019 -
Turning Chronic Illness into a Fashion Statement
Published: 11/6/2019 -
Connecting Young Adults with Rare and Chronic Conditions
Published: 10/30/2019 -
Helping Caregivers Care for Themselves
Published: 10/23/2019 -
A Festival of Moving Pictures
Published: 10/16/2019 -
Deep Genomics Boasts an AI First in Drug Discovery
Published: 10/9/2019 -
How to Live with a Disability with Your Mojo Intact
Published: 10/3/2019 -
Why a Big Pharma Exec Embraced Rare Neurological Diseases
Published: 9/25/2019
RARECast is a Global Genes podcast hosted by award-winning journalist Daniel Levine. It focuses on the intersection of rare disease with business, science, and policy.